K. Michael Cummings, PhD, MPH
K. Michael Cummings, PhD, MPH, is a recent a recruit to MUSC having joined the faculty in October 2011. He is Professor, Department of Psychiatry & Behavioral Sciences and co-director (with Dr. Matt Carpenter) of the Tobacco Policy and Control Program at the Hollings Cancer Center. His 30 year research career has focused on understanding factors involved in predicting uptake and cessation of tobacco use and the testing of interventions to alter tobacco use behaviors at both the individual and population level. He is currently the principal investigator of a NIH funded program project which involves a multi-institutional research consortium established to evaluate the psychosocial, behavioral, and product-related impacts of the tobacco control policies which are part of the World Health Organization’s Framework Convention on Tobacco Control (FCTC). This international project which includes a wide range of research studies from those focused on biological factors that influence tobacco use to the impact of health warnings and public education campaigns on representative populations of smokers. Dr. Cummings previously was the founder and director of the New York State Smoker’s Quit Line which during his tenure was one of the busiest quit line services in the world. In 2009, Dr. Cummings received the prestigious Luther L. Terry Award from the American Cancer Society for his career achievements in tobacco control research.
| ||OBJECTIVES |
| ||At the completion of this session, the participant will be able to:|
1. Describe historical and recent trends in tobacco use behaviors, i.e., types of tobacco products consumed, amount of tobacco
use, uptake and cessation of tobacco.
2. Describe changing trends in the characteristics of those using tobacco products, i.e., age, race, education, co-morbidities.
3. Describe the evidence supporting population and clinical interventions to reduce tobacco use.